Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease.
Fiche publication
Date publication
avril 2023
Journal
The American journal of medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick
Tous les auteurs :
Patel S, Lam PH, Kanonidis E, Ahmed AA, Raman VK, Wu WC, Rossignol P, Arundel C, Faselis C, Kanonidis IE, Deedwania P, Allman RM, Sheikh FH, Fonarow GC, Pitt B, Ahmed A
Lien Pubmed
Résumé
Renin-angiotensin system inhibitors improve outcomes in patients with heart failure with reduced ejection fraction (HFrEF). However, less is known about their effectiveness in patients with HFrEF and advanced kidney disease.
Mots clés
Heart failure, advanced kidney disease, hospitalization, mortality, renin-angiotensin system inhibitors
Référence
Am J Med. 2023 04 3;: